AVITA Medical (RCEL) Change in Receivables (2019 - 2025)
AVITA Medical (RCEL) posted Change in Receivables of -$81000.0 for Q4 2025, down 103.46% on a QoQ basis from $2.3 million in Q3 2025, and up 94.56% year-over-year from -$41632.4 in Q4 2024.
AVITA Medical (RCEL) Change in Receivables (2019 - 2025) Analysis & Trends
AVITA Medical's Change in Receivables history runs 7 years deep, the most recent figure standing at -$81000.0 for Q4 2025.
- Quarterly Change in Receivables rose 94.56% year-over-year to -$81000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.6 million (up 187.65% YoY) and the FY2025 annual result came in at $3.6 million, up 187.65% from the prior year.
- Change in Receivables was -$81000.0 for Q4 2025 at AVITA Medical, down from $2.3 million in the prior quarter.
- Across five years, Change in Receivables topped out at $2.3 million in Q3 2025 and bottomed at -$1.7 million in Q4 2023.
- A 5-year average of -$409705.9 and a median of -$362000.0 in 2022 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables slumped 4481.82% — and 2025, when it surged 254.83%.
- AVITA Medical's Change in Receivables stood at -$1.2 million in 2021, then jumped by 192.73% to $1.1 million in 2022, then slumped by 253.06% to -$1.7 million in 2023, then gained by 12.36% to -$1.5 million in 2024, then jumped by 94.56% to -$81000.0 in 2025.
- Business Quant data shows RCEL's Change in Receivables at -$81000.0 in Q4 2025, $2.3 million in Q3 2025, and $1.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | -81,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -81,000.00 |
| Dec 31, 2025 | -81,000.00 |
| Sep 30, 2025 | 2.34 Mn |
| Sep 30, 2025 | 2.34 Mn |
| Jun 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 1.63 Mn |
| Mar 31, 2025 | -253,000.00 |
| Mar 31, 2025 | -253,000.00 |
| Dec 31, 2024 | -1.49 Mn |
| Dec 31, 2024 | -1.49 Mn |
| Sep 30, 2024 | -1.51 Mn |
| Sep 30, 2024 | -1.51 Mn |
| Jun 30, 2024 | -1.65 Mn |
| Jun 30, 2024 | -1.65 Mn |
| Mar 31, 2024 | 503,000.00 |
| Mar 31, 2024 | 503,000.00 |
| Dec 31, 2023 | -1.70 Mn |
| Dec 31, 2023 | -1.70 Mn |
| Sep 30, 2023 | -33,000.00 |
| Sep 30, 2023 | -33,000.00 |